A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer.
<h4>Background</h4>Up to 80% of patients dying from prostate carcinoma have developed bone metastases that are incurable. Castration is commonly used to treat prostate cancer. Although the disease initially responds to androgen blockade strategies, it often becomes castration-resistant (...
Guardado en:
Autores principales: | Anaïs Fradet, Hélène Sorel, Baptiste Depalle, Claire Marie Serre, Delphine Farlay, Andrei Turtoi, Akeila Bellahcene, Hélène Follet, Vincent Castronovo, Philippe Clézardin, Edith Bonnelye |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eafaa204b5594d94961e809b03c8f723 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fracture Risk Evaluation of Bone Metastases: A Burning Issue
por: Cyrille B. Confavreux, et al.
Publicado: (2021) -
Percutaneous Vertebroplasty for Osteolytic Spinal Lesion. A Pilot Study
por: Mohamed Amer
Publicado: (2013) -
Endonuclease increases efficiency of osteoblast isolation from murine calvariae
por: Yosuke Asano, et al.
Publicado: (2021) -
Circulating microRNAs Correlate with Multiple Myeloma and Skeletal Osteolytic Lesions
por: Sara Reis Moura, et al.
Publicado: (2021) -
Retrospective Analysis of 10 Cases of Disseminated Nontuberculous Mycobacterial Disease with Osteolytic Lesions
por: Tang M, et al.
Publicado: (2021)